Addictive Potential: Unknown
Emergency Room Visits Yearly: Unknown
Mandatory Minimum Sentence: Unknown
Mechanism of Action: NMDA antagonist and dopamine reuptake inhibitor
4-MeO-PCP is also known as 4-Methoxyphencyclidine and methoxydine. It is a dissociative anesthetic drug with hallucinogenic and sedative effects. It is research chemical that is structurally related to the dissociative drug PCP. Distribution of 4-Meo-PCP among recreational users was first detected by the European Early Warning System in 2011.
|Mecke Reagent||Marquis Reagent|
|4-MeO-PCP||yellow to green to red||slow red|
(Info provided by Morris, 2012)
Side Effects and Adverse Reactions:
4-MeO-PCP is a very new substance, and little is known about its side effects, adverse reactions, long term damage, and/or addiction potential.
Erowid (2012) lists various negative effects reported by recreational users. These effects, which may increase with redosing, include:
- Disturbing hallucinations and/or delusions
- Anxiety, paranoia
- Severe dissociation, depersonalization
- Ataxia (loss of motor coordination)
- Psychotic episodes
- Nausea, vomiting
- Temporary amnesia
- Severe distortion or loss of auditory/visual perception
Remember, research chemicals are experimental chemicals that may not be safe for human consumption. This is because not enough data exists currently about their effects in humans. Although some people are willing to ingest research chemicals, it is unreasonable to assume that they are in any way safe to use recreationally.